Attune Neurosciences, Inc.
Company
US neurotech company based in Menlo Park, California, founded in 2019 by CEO Rajiv Mahadevan with Stanford researchers Keith Murphy and Luis de Lecea, plus Pablo Villoslada (clinical development). Developer of ATTN201, an investigational wearable headband that delivers low-intensity focused ultrasound to deep brain targets. Names tinnitus among its intended targets alongside sleep, depression, pain and movement disorders, but has no registered tinnitus trial as of October 2026. In a private email (14 Oct 2026), CEO Rajiv Mahadevan reported unpublished early results showing substantial tinnitus reduction in over half of participants in its trials. Funded by venture investors, the NIH and U.S. Special Operations Command, and selected in May 2026 for ARPA-H's EVIDENT behavioral-health program.